Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression

被引:74
|
作者
Mailloux, Adam W. [2 ]
Young, M. Rita I. [1 ,3 ,4 ]
机构
[1] Ralph H Johnson VA Med Ctr, Res Serv 151, Charleston, SC 29401 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA
[3] Med Univ S Carolina, Dept Otolaryngol, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
关键词
regulatory T cell; Treg; migration; trafficking; localization; chemokine; inflammation; cancer; immune suppression; TRANSCRIPTION FACTOR FOXP3; DRAINING LYMPH-NODES; BONE-MARROW; DENDRITIC CELLS; CHEMOKINE RECEPTOR; HEPATOCELLULAR-CARCINOMA; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; HUMAN THYMOCYTES; OVARIAN-CANCER;
D O I
10.1615/CritRevImmunol.v30.i5.30
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs) have become a priority for many investigators in immunology due to their potent immunosuppressive and tolerogenic effects. While Treg activity is required for normal immune homeostasis, dysregulation of their numbers can induce autoimmunity or aid in the pathogenesis of disease. Therefore, great effort has been made to understand the mechanisms by which Tregs accumulate in different areas of the body. Like other lymphocytes, Tregs migrate in response to a network of chemotactic stimuli involving chemokines, chemokine receptors, integrins, and their corresponding ligands. However, many of these stimuli are exclusive to Tregs, inducing their migration while leaving conventional populations unaffected. It is these selective stimuli that result in increased ratios of Tregs among conventional effector populations, leading to changes in immune suppression and homeostasis. This review explores selective Treg trafficking during thymic Treg development, migration to secondary lymphoid tissues and emigration into the periphery during homeostatic conditions, inflammation, and the tumor microenvironment, placing emphasis on stimuli :hat selectively recruits Tregs to target locations.
引用
收藏
页码:435 / 447
页数:13
相关论文
共 50 条
  • [1] VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
    Ohm, JE
    Gabrilovich, DI
    Sempowski, GD
    Kisseleva, E
    Parman, KS
    Nadaf, S
    Carbone, DP
    BLOOD, 2003, 101 (12) : 4878 - 4886
  • [2] Thymic and peripheral regulatory T-cell development
    Hsieh, Chvi-Song
    Lio, Chan Wang
    Lathrop, Stephanie K.
    Bautista, Jhoanne
    Lee, Hyang Mi
    San, Nicole
    CYTOKINE, 2008, 43 (03) : 305 - 305
  • [3] CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
    Jin, Dachuan
    Fan, Jie
    Wang, Long
    Thompson, Linda F.
    Liu, Aijie
    Daniel, Benjamin J.
    Shin, Tahiro
    Curiel, Tyler J.
    Zhang, Bin
    CANCER RESEARCH, 2010, 70 (06) : 2245 - 2255
  • [4] CIMETIDINE BLOCKS THE DEVELOPMENT OF TUMOR-INDUCED SUPPRESSOR T-CELL ACTIVITY
    BENNETT, JA
    ZLOTY, P
    MCKNEALLY, MF
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1982, 4 (04): : 280 - 280
  • [5] Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists
    Dana A. Emerson
    William L. Redmond
    BioDrugs, 2018, 32 : 221 - 231
  • [6] Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists
    Emerson, Dana A.
    Redmond, William L.
    BIODRUGS, 2018, 32 (03) : 221 - 231
  • [7] Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects
    Inkyu Hwang
    Nguyet Nguyen
    Archives of Pharmacal Research, 2015, 38 : 1415 - 1433
  • [8] Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects
    Hwang, Inkyu
    Nguyen, Nguyet
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (08) : 1415 - 1433
  • [9] Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
    Pratima Sinha
    Virginia K. Clements
    Seth Miller
    Suzanne Ostrand-Rosenberg
    Cancer Immunology, Immunotherapy, 2005, 54 : 1137 - 1142
  • [10] Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
    Sinha, P
    Clements, VK
    Miller, S
    Ostrand-Rosenberg, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) : 1137 - 1142